Skip to main content

CORRECTION article

Front. Pharmacol., 29 March 2023
Sec. Inflammation Pharmacology

Corrigendum: Induced expression of kir6.2 in A1 astrocytes propagates inflammatory neurodegeneration via Drp1-dependent mitochondrial fission

Nanshan SongNanshan Song1Hong ZhuHong Zhu1Rong XuRong Xu1Jiaqi LiuJiaqi Liu1Yinquan FangYinquan Fang1Jing ZhangJing Zhang1Jianhua DingJianhua Ding1Gang Hu,
Gang Hu1,2*Ming Lu,
Ming Lu1,3*
  • 1Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
  • 2Department of Pharmacology, Nanjing University of Chinese Medicine, Nanjing, China
  • 3Neuroprotective Drug Discovery Key Laboratory, Department of Pharmacology, Nanjing Medical University, Nanjing, China

A Corrigendum on
Induced expression of kir6.2 in A1 astrocytes propagates inflammatory neurodegeneration via Drp1-dependent mitochondrial fission

by Song N, Zhu H, Xu R, Liu J, Fang Y, Zhang J, Ding J, Hu G and Lu M (2021). Front. Pharmacol. 11:618992. doi: 10.3389/fphar.2020.618992

In the published article, there was an error in Figure 6 as published. Due to the unsuccessful replacement of the Western blotting band based on Figure 4H as the lay-out template, the β-actin band in Figure 6C was inadvertently duplicated with the β-actin band in Figure 4H. Similarly, the original legend of Figure 6C was a repeated writing of the legend in Figure 4H and displayed as “(C) Expression of C3 in the midbrain were detected by Western blotting and its densitometric analysis.” The correct legend is “(C) Expression of C3 in primary astrocytes detected by Western blotting and its densitometric analysis.” From a more rigorous perspective, we reviewed the statistical data and re-plotted the statistical histogram in Figure 6C. The corrected Figure 6C and the legend appear below. The authors provided the journal with the source data files. Results and conclusions were not affected.

FIGURE 6
www.frontiersin.org

FIGURE 6. Kir6.2-deficient astrocytes are resistant to neurotoxic A1-like phenotype in vitro. (A) Protocol of treatment for (B–J). Primary microglia from WT mice were stimulated with 100 ng/mL LPS for 24 h to collect the MCM. For primary astrocytes cultures, the MCM was diluted at a ratio of 1:3 to incubate the primary astrocytes from WT and kir6.2−/− mice for 24 h. (B) Heat map comparing the mean expression of A1-specific transcripts in astrocytic RNA samples by RT-PCR. (C) Expression of C3 in primary astrocytes detected by Western blotting and its densitometric analysis. (D) Immunofluorescent stainings of C3 (green) and GFAP (red) in primary astrocytes. (E) Representative images of JC-1 stain in astrocytes were observed by confocal microscopy. Hoechst stains nucleus (blue). (F) Flow cytometric analysis of astrocytes stained with JC-1 fluorescent probe. (G) Quantification of MMP loss in JC-1 staining measured by flow cytometry. (H) ATP contents of astrocytes were analyzed. (I) Astrocytes were stained with MitoSOX fluorescent probe and analyzed by flow cytometry. (J) Quantification of the mitochondrial ROS by MitoSOX staining. Data were analyzed using two-way ANOVA. *p < 0.05 and ***p < 0.001 vs. corresponding CON-MCM group. #p < 0.05 and ###p < 0.001 vs. WT LPS-MCM group. Values are presented as means ± SEM from three independent experiments.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: neuroinflammation, astrocytes, mitochondrial fission, Parkinson’s diseases, kir6.2

Citation: Song N, Zhu H, Xu R, Liu J, Fang Y, Zhang J, Ding J, Hu G and Lu M (2023) Corrigendum: Induced expression of kir6.2 in A1 astrocytes propagates inflammatory neurodegeneration via Drp1-dependent mitochondrial fission. Front. Pharmacol. 14:1111925. doi: 10.3389/fphar.2023.1111925

Received: 06 December 2022; Accepted: 20 March 2023;
Published: 29 March 2023.

Edited by:

Paola Patrignani, University of Studies G. d’Annunzio Chieti and Pescara, Italy

Reviewed by:

Annalisa Contursi, University of Studies G. d’Annunzio Chieti and Pescara, Italy

Copyright © 2023 Song, Zhu, Xu, Liu, Fang, Zhang, Ding, Hu and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Gang Hu, ghu@njmu.edu.cn; Ming Lu, lum@njmu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.